Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations

The EMBO Journal
R K BrachmannJ D Boeke

Abstract

Several lines of evidence suggest that the presence of the wild-type tumor suppressor gene p53 in human cancers correlates well with successful anti-cancer therapy. Restoration of wild-type p53 function to cancer cells that have lost it might therefore improve treatment outcomes. Using a systematic yeast genetic approach, we selected second-site suppressor mutations that can overcome the deleterious effects of common p53 cancer mutations in human cells. We identified several suppressor mutations for the V143A, G245S and R249S cancer mutations. The beneficial effects of these suppressor mutations were demonstrated using mammalian reporter gene and apoptosis assays. Further experiments showed that these suppressor mutations could override additional p53 cancer mutations. The mechanisms of such suppressor mutations can be elucidated by structural studies, ultimately leading to a framework for the discovery of small molecules able to stabilize p53 mutants.

References

Apr 1, 1992·Nature Genetics·W S el-DeiryB Vogelstein
Jan 1, 1992·Genes, Chromosomes & Cancer·C Caron de Fromentel, T Soussi
Aug 21, 1992·Cell·B Vogelstein, K W Kinzler
Feb 1, 1992·Yeast·D MuhlradR Parker
Apr 11, 1992·Nucleic Acids Research·E Schärer, R Iggo
May 8, 1992·Science·S E KernB Vogelstein
Jul 25, 1992·Nucleic Acids Research·K Robzyk, Y Kassir
Jul 5, 1991·Science·M HollsteinC C Harris
Jan 1, 1991·Journal of Cellular Biochemistry·D MichalovitzM Oren
Sep 1, 1995·Nature Medicine·J Milner
Sep 1, 1995·Genes & Development·Y HauptM Oren
Feb 1, 1995·Current Opinion in Genetics & Development·R Haffner, M Oren
Mar 1, 1995·Nature Genetics·B C Hann, D P Lane
Oct 21, 1994·Cell·J B Gibbs, A Oliff
Nov 4, 1994·Science·S W LoweT Jacks
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J A PietenpolB Vogelstein
Jul 7, 1994·The New England Journal of Medicine·K W Kinzler, B Vogelstein
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Jul 11, 1993·Nucleic Acids Research·T R HuppD P Lane
Oct 28, 1993·The New England Journal of Medicine·C C Harris, M Hollstein
Nov 1, 1995·Current Opinion in Oncology·S W Lowe
Jan 1, 1996·Genes & Development·E White
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·R K BrachmannJ D Boeke
May 1, 1996·Genes & Development·L J Ko, C Prives
Jun 7, 1996·Biochimica Et Biophysica Acta·T M Gottlieb, M Oren
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·M VidalJ D Boeke
Oct 1, 1996·Nature Medicine·A M WieczorekT D Halazonetis
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·G J MiroyJ W Kelly
Feb 1, 1997·Current Opinion in Genetics & Development·R Hansen, M Oren
Mar 1, 1997·Trends in Microbiology·J C NeilE W Baxter

❮ Previous
Next ❯

Citations

Jun 17, 2005·Journal of Physiology and Biochemistry·M Gomez-LazaroJ Jordán
Nov 21, 2013·Journal of Molecular Modeling·Shruti KoulgiRajendra Joshi
Jun 7, 2013·Molecules and Cells·Hyung Jin ChaKwan Yong Choi
Mar 5, 2009·Apoptosis : an International Journal on Programmed Cell Death·Chao Lu, Wafik S El-Deiry
Jan 31, 2013·Nature Communications·Christopher D WassmanRommie E Amaro
Aug 25, 2009·The Journal of Biological Chemistry·Kian Hoe KhooAlan R Fersht
Apr 27, 2011·The Journal of Biological Chemistry·Chia-Wen HoJaulang Hwang
Dec 26, 2008·Molecular Biology of the Cell·Gregory H TullyDavid O Morgan
Nov 15, 2001·The EMBO Journal·T WangR K Brachmann
Jun 29, 2010·Nucleic Acids Research·Roberta BaronioPeter Kaiser
Oct 7, 2006·Current Opinion in Gastroenterology·T Lerut, G Decker
Jun 3, 2010·Cold Spring Harbor Perspectives in Biology·Andreas C Joerger, Alan R Fersht
Apr 22, 1999·Protein Science : a Publication of the Protein Society·I Matsumura, A D Ellington
Jan 7, 2011·Science Translational Medicine·Anna Mandinova, Sam W Lee
Apr 16, 2008·Annual Review of Biochemistry·Andreas C Joerger, Alan R Fersht
Apr 22, 2010·Molecular Cancer Research : MCR·Jennifer J JordanMichael A Resnick
Sep 17, 2009·PLoS Computational Biology·Samuel A DanzigerRichard H Lathrop
Nov 1, 2012·PloS One·Tobias BrandtDmitry B Veprintsev
Jul 17, 2004·Biological Chemistry·Charleen RupnarainKanti Bhoola
Feb 23, 2011·International Journal of Molecular Sciences·Davide PirolliMaria Cristina De Rosa
May 4, 2012·International Journal of Biological Sciences·Shuting JiaYing Luo
Mar 1, 2014·Nature Reviews. Drug Discovery·Kian Hoe KhooDavid P Lane
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·K B WongA R Fersht
Aug 18, 2001·Journal of Endocrinological Investigation·N R Farid
Mar 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Timothy E BaroniRainer K Brachmann
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Andreas C JoergerAlan R Fersht
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·B K KennedyM Vidal
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·P V NikolovaA R Fersht
Apr 29, 2014·FEBS Letters·Vladimir J N Bykov, Klas G Wiman
Feb 19, 2010·Translational Oncology·Zhen Wang, Yi Sun
Jul 6, 2007·Journal of Molecular Biology·Chen Xue FenFarid J Ghadessy
Aug 2, 2003·European Journal of Haematology·Claudete Esteves KlumbFranklin David Rumjanek
Jan 23, 2014·Human Mutation·Alessandra BisioPaola Monti
Oct 20, 2006·IEEE/ACM Transactions on Computational Biology and Bioinformatics·Samuel A DanzigerRichard H Lathrop

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2022 Meta ULC. All rights reserved